OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-09-30-accounts

The British Dermatological Nursing Group (Limited by Guarantee)

Report and unaudited Financial Statements

Year Ended

30 September 2025

Company number 07035369 Charity number 1133259

THE BRITISH DERMATOLOGICAL NURSING GROUP

(Limited by Guarantee)

Annual report and unaudited financial statements for the year ended 30 September 2025

Contents
Page:
2 Report of the Trustees
9 Independent examiner’s report
10 Statement of financial activities
11 Balance sheet
12 Statement of cash flows
13 Notes forming part of the financial statements

Directors/Trustees

Elizabeth McGovern (President) Karen Stephen Elizabeth Lusted Valerie Anderson Pauline Stopford-Taylor Emmanuel Toni

Secretary and Registered Office

Susan Maguire The Clubhouse 20 St Andrew Street London EC4A 3AG

Company number

07035369

Charity number

1133259

1

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025

The Trustees present their report and the unaudited financial statements for the year ended 30 September 2025.

The Trustees who served throughout the year were:

Elizabeth McGovern (President) Karen Stephen Elizabeth Lusted Valerie Anderson Pauline Stopford-Taylor Emmanuel Toni

Secretary

Susan Maguire

Independent examiner

Chesterton Consultancy Ltd 42 Abbotsbury Gardens Pinner Middlesex HA5 1SX

Solicitors

B P Collins Collins House 32-38 Station Road Gerrards Cross Buckinghamshire SL9 8EL

2

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025 (Continued)

Structure, Governance and Management Governing document

The British Dermatological Nursing Group was incorporated on 30th September 2009 and is established as a company limited by guarantee and registered as a charity with the Charity Commission. The affairs of the Group are governed by its Memorandum and Articles of Association and managed by a Board of Directors who are Trustees of the Charity. The liability of each member in the event of the Group being wound up is limited to a sum not exceeding £1.

The British Dermatological Nursing Group was originally formed in 1989 as an unincorporated charity (No. 1077252). This charity ceased activity on the 31st May 2010 and its assets, totalling £262,898 were transferred to the new incorporated charity as of that date under a Transfer of Assets resolution dated 21st April 2010.

The directors of the company are also charity trustees for the purposes of charity law and under the company's Articles are known as Committee Members of the Charity. At a previous Annual General Meeting a vote was taken to change the articles of association allowing executive committee members to serve for up to 5 years on the committee and for there to be a maximum of seven Committee Members. No Committee Member shall be eligible for re-election for a period of 12 months from the date that his or her office comes to an end.

Objectives and Aims

The unincorporated British Dermatological Nursing Group was formed in 1989 after recognising the need for a low-cost educational platform to assist nurses in developing their skills and experience in dermatological nursing. The Group has a Constitution that is reviewed on an annual basis to ensure that it reflects the changing needs of the members as well as that of the Charities Commission. Any amendments to the Constitution are voted in by the Group at the Annual General Meeting.

The Group has referred to the guidance in the Charity Commission's general guidance on Public Benefit when reviewing its aims and objectives and in planning its future activities and the trustees believe that the activities undertaken are of clear benefit to the public and in accordance with the aims and objectives set. Specifically, the objects of the Group are to preserve and protect health and relieve sickness by maintaining and improving standards of practice in dermatological nursing for the public benefit.

Key management and remuneration

The trustees consider the board of Trustees and the Chief Executive Officer as comprising the key management personnel of the charity in charge of directing and controlling the charity and running and operating the charity on a day to day basis. Trustees are responsible for the management of The British Dermatological Nursing Group for which they receive no remuneration. The remuneration of the Chief Executive Officer is agreed by the Trustees when reviewing the previous year's annual accounts. The Chief Executive Officer’s remuneration is aligned to job roles and appropriate pay scales within both the private and NHS sectors.

Recruitment and appointment of new trustees

It is the existing Trustees' responsibility to identify potential Trustees with appropriate skills and background from the Group's membership. Trustees are elected annually and reflect the national membership of the group. The Trustees are elected for a fixed term of office. Following this term, they retire from the position of Trustee.

3

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025 (Continued)

Risk management

The British Dermatological Nursing Group has a comprehensive Risk Assessment Policy which categories the impact of the principal risks to the Group. The key risks are the continuance of both sufficient corporate sponsorship and the possible impact this could have on financial planning and management and the income generated with the annual conference event. Forthcoming events are planned in light of both of these sources of income. This is regularly discussed and monitored at Trustee Meetings which are attended by the Trustees and the Chief Executive Officer.

Potential corporate sponsors are investigated, and the Trustees would consider diversification in other activities and sources of income if required.

Principle funding sources

During the period the charity received corporate sponsorship of £684,116 (2024 - £450,940). In addition, it received conference related income of £104,480 (2024 - £313,127), educational meeting fees of £25,730 (2024 - £20,310) and subscriptions of £40,734 (2024 - £36,396).

Strategies

Development of strategic aims for the group to:

Through the development of subgroups, the Group continues to offer peer support and information sharing. These subgroups report directly to the Committee and the Chair of each of these groups is a co-opted member of the Committee.

The Group continues to have representation of various external groups from within the Committee and also identified Group members. These representatives report directly to the Committee.

4

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025 (Continued)

Achievements and Performance

Charitable Activities

The British Dermatological Nursing Group (BDNG) continued to deliver its charitable objectives over the last year by supporting dermatology nursing professionals through education, professional development, and opportunities for collaboration and networking. Activities were focused on advancing standards of care in dermatology, sharing best practice, and fostering a supportive professional community.

Annual Conference

The 34th Annual BDNG Conference was the flagship activity of the year with over 470 delegates in attendance. The three-day event provided a comprehensive programme of education and professional development, alongside structured opportunities for networking and peer support.

The conference brought together dermatology nurses and allied professionals from across the UK and Ireland, enabling delegates to:

The scale of attendance and the longevity of the conference demonstrate its ongoing value to the dermatology nursing community and its alignment with BDNG’s charitable aims.

Educational Meetings and Masterclasses

In addition to the annual conference, BDNG delivered further educational activities during the year, including:

These events supported continued professional development and addressed specialist areas of dermatological practice.

Celebrating Dermatology Nurses

The BDNG hosted our second award event in Belfast. The categories were Stone Achievement Award for an outstanding contribution to dermatological nursing, Team of the Year Award in collaboration with the British Association of Dermatologists, Innovation Award, Rising Star Award and Patient Choice Award. There were a significant increase in nominations across all categories.

Member Engagement and Service Mapping

During the year, BDNG undertook a membership survey to measure member satisfaction and identify priorities for future activity. In addition, a dedicated survey was conducted to build a comprehensive map of dermatology nursing services across the UK and Ireland. This work supports improved understanding of workforce distribution, service provision, and professional needs within dermatology nursing.

5

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025 (Continued)

Strategic Development

BDNG commenced work on the development of a five-year strategic plan. This process is intended to provide a clear framework for future activity, ensure sustainability, and align the Group’s work with the evolving needs of dermatology nurses and patients.

International Representation

BDNG was invited to attend the International League of Dermatological Societies (ILDS) World Skin Summit in Cape Town. BDNG was the only nursing organisation represented, providing a unique opportunity to engage with global dermatology associations. Attendance strengthened international relationships and reinforced the essential role of nurses within dermatology care worldwide.

Representative of the BDNG attended the EADV conference in Paris and took part in a European wide nurse summit as well as presenting at the Nurse Meeting.

Public Benefit

BDNG’s activities during the year delivered public benefit by:

Governance and Future Focus

The Group remained committed to good governance and the effective use of resources in support of its charitable objectives.

Plans for the Coming Year

Planned activities for the next year include:

These initiatives are intended to strengthen professional support for dermatology nurses and further enhance patient care.

6

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025 (Continued)

Investment policy and Objectives

The constitution authorises the trustees to apply the assets and property of the Charity solely towards the promotion and purpose of The British Nursing Dermatological Group as laid down in the constitution.

Reserves Policy

Any funds provided to the British Dermatological Nursing Group for a specific purpose are classed as a restricted reserve. Trustees are resolved to limit spending each year to an amount considered to balance the interest of the current and future beneficiaries of the Group's work.

The trustees have established a policy of retaining funds equivalent to 6 months of expenditure in order to protect the Society’s core activities in the event of a shortfall in income. This was estimated to be approximately £300,000. Although the amounts in reserve exceed the target, over the years the organisation has seen fluctuations in financial results from year to year and therefore the trustees do not see the level of reserves as excessive. Furthermore, the trustees intend to continue to use any excess reserves to focus on new initiatives, as referred to in this report.

Unrestricted reserves at the balance sheet date totalled £715,741 (2024 - £588,521) and restricted reserves of £Nil (2024 - £Nil).

Qualifying 3[rd] Party Indemnity Provisions

The charitable company has granted an indemnity to its trustees against liability in respect of actions brought by third parties, subject to the conditions set out in the Companies Act 2006. Such qualifying third-party indemnity provision remains in force as at the date of approving the Trustees’ Report.

7

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Report of the Trustees for the year ended 30 September 2025 (Continued)

Statement of Trustees’ Responsibilities

The trustees (who are also directors of The British Dermatological Nursing Group for the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year. In preparing those financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Signed on behalf of Trustees

Elizabeth McGovern

Elizabeth McGovern Chair

Dated: 16[th] April 2026

8

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Independent Examiners Report to the members of The British Dermatological Nursing Group

_______________

I report to the charity trustees on my examination of the accounts of The British Dermatological Nursing Group for the year ended 30[th] September 2025.

Responsibilities and basis of report

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner's statement

Since the Company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Chartered Institute of Management Accountants, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Graham Bolton

Graham Bolton F.C.M.A. For and on behalf of Chesterton Consultancy Ltd Management Accountant

Date: 29[th] April 2026 42 Abbotsbury Gardens Pinner Middlesex HA5 1SX

9

THE BRITISH DERMATOLOGICAL NURSING GROUP

(Limited by Guarantee)

Statement of financial activities (incorporating an income and expenditure account) for the year ended 30 September 2025

Unrestricted Restricted
Funds
Funds
Note
£
£
Income and endowments from:
Corporate sponsorship
681,616
2,500
Subscriptions
40,734
-
Investments
2
-
Charitable activities
Educational meeting attendance fees
25,730
-
Annual Conference
104,480
-
_
_
Total income
852,560
2,500
_
_
Expenditure on:
Raising funds
Fundraising costs
3
133,810
-
Charitable activities:
Education and educational meetings
4
591,530
2,500
Donations
-
-
_
_
Total expenditure
725,340
2,500
Net (expenditure)/income
127,220
-
Resources b/fwd
588,521
-
__
_____
Balance as at 30 September 2025
715,741
-		 2025
2024
Total
Total
£
£
684,116
450,940
40,734
36,396
505
25,730
20,310
104,480
313,127
_
_
855,060
821,278
_
_
133,810
122,439
594,030
666,228
-
50,000
_
__
727,840
838,667
127,220
(17,389)
588,521
605,910
_
___
715,741
588,521

All amounts relate to continuing activities.

All gains and losses recognised in the year are included above.

The notes on pages 13 to 18 form part of these financial statements.

10

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Balance sheet at 30 September 2025

Unrestricted Restricted
Funds
Funds
2025
Total
Note
£
£
£
Fixed assets
Tangible assets
9
2,978
-
2,978
Current assets
Debtors
10
370,923
-
370,923
Cash and bank balances
685,457
-
685,457
__
_
__
1,056,380
-
1,056,380
Creditors: amounts falling
within one year
11
(343,617)
-
(343,617)
_
_
_
Net current assets
712,763
-
712,763
_
_
_
Net assets
715,741
-
715,741
_
__
_____
Financed by:
Unrestricted funds
12
715,741
Restricted Funds
-
_
715,741		 2024
Total
£
6,726
414,701
424,433
_
839,134
(257,339)
_
581,795
_
588,521
_
588,521
-
______
588,521

For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006. They also acknowledge their responsibility for preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue on 16[th] April 2026 and signed on its behalf by:

Elizabeth McGovern

______ Elizabeth McGovern Trustee (Chair)

The notes on pages 13 to 18 form part of these financial statements.

Company Registration No. 07035369

11

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Statement of Cash Flows for the year ended 30 September 2025

2025 2024
£ £
Cash flows/(Loss) from operating activities
Net (expenditure)/income for the year 127,220 (17,389)
Add back depreciation 3,748 4,227
______ ______
130,968 (13,162)
Purchase of fixed assets - (2,961)
Adjustments for:
Interest receivable - (505)
Decrease/(increase) in debtors 43,778 (157,302)
Increase/(decrease) in creditors 86,278 148,694
_ _
Net cash generated/(used) in operating activities 261,024 (25,236)
Cash flows from investing activities
Interest received from investments - 505
_ _
Net cash (used in) / provided by investing activities - 505
_ _
Cash flows from financing activities - -
_ _
Change in cash and cash equivalents in the reporting period 261,024 (24,731)
Cash and cash equivalents at the beginning of the year 424,433
449,164
_ _
Cash and cash equivalents at the end of the year 685,457 424,433
_ _

12

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Notes forming part of the financial statements for the year ended 30 September 2025

1 Accounting policies

The British Dermatological Nursing Group is a company limited by guarantee, domiciled and incorporated in England and Wales. The registered office is The Clubhouse, 20 St Andrew Street, London. EC4A 3AG.

Basis of accounting

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention

The financial statements are prepared in sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest pound.

Going Concern

The trustees assess whether the use of going concern is appropriate i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the company to continue as a going concern.

The company made a surplus for the year of £127,220, and had net assets of £715,741 as at 30 September 2025. The total of cash reserves as at the year-end was £685,457 and remain profitable post year end.

The trustees make this assessment in respect of a period of one year from the date of the approval of the financial statements and have concluded that there are no material uncertainties about the charity's ability to continue.

.

Income

Subscriptions, sponsorship and other income is accounted for in the year in which it is receivable. Income from attendance fees for educational meetings is recognised in the year in which they are held.

Where a sponsorship has been specified as relating to a future accounting period, the income is deferred until that period. All income deferred in the previous year has been recognised in the current year.

Income from investments

Bank interest is accounted for when received.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to the expenditure. Expenses are accounted for on an accruals basis.

13

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Notes forming part of the financial statements for the year ended 30 September 2025 (Continued)

1 Accounting policies (continued)

Costs of generating funds comprise of those costs directly attributable to generating sponsorship income.

Charitable activities include all expenditure incurred in pursuance of the Society’s objectives.

Governance costs comprise of all costs involving the public accountability of the charity and its compliance with regulation and good practice. These costs include costs related to the preparation and examination of the financial statements, other professional and legal fees.

Support costs include general administrative costs and are apportioned to appropriate expense categories on a percentage of total cost basis.

Tangible fixed assets and Depreciation

Tangible fixed assets are included at cost. Depreciation is provided to write off the cost, less estimated residual values, of all tangible fixed assets, evenly over their expected useful lives. It is calculated at the following rates:

Computer equipment - 25% per annum straight line
Plant & machinery - 20% per annum straight line

Financial instruments

Cash and cash equivalents comprise cash at banks and in hand, including short term deposits with a maturity date of up to 12 months.

Debtors and Creditors

Debtors and creditors receivable or payable within one year of the reporting date are carried at their transaction price.

Funds

Unrestricted funds comprise of the accumulated excess of incoming resources over resources expended on the Statement of Financial Activities. They are available for use at the discretion of the Trustees in furtherance of the general objectives of the Society.

Restricted funds comprise of the accumulated excess of incoming resources over resources expended on the Statement of Financial Activities and are only available for their specified use.

Taxation

No provision has been made for taxation as the Society’s status renders it exempt from UK direct taxation.

14

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Notes forming part of the financial statements for the year ended 30 September 2025 (Continued)

1 Accounting policies (continued)

Judgements and key sources of estimation uncertainty

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant.

The judgement that management has made in the process of applying the charity’s accounting policies which has the most significant effect on the amounts recognised in the accounts is the allocation of support costs across activities.

2 Investment income

Interest on cash deposits
3
Costs of generating funds
External fundraising costs
Support costs

4
Charitable activities
Educational meeting costs
Conference costs
Journal costs
Awards
Other charitable costs
Support costs
 2025
2024
£
£
-
505
__
_
2025
2024
£
£
67,880
75,234
65,930
47,205


133,810
122,439

__
2025
2024
£
£
58,199
44,501
69,564
172,292
63,878
67,027
45,970
94,830
68,866
30,722
287,553
256,856
_
______
594,030
666,228

15

THE BRITISH DERMATOLOGICAL NURSING GROUP

(Limited by Guarantee)

Notes forming part of the financial statements for the year ended 30 September 2025 (Continued)

5
Support costs
Salaries and related payroll costs
Travel & subsistence
Office expenses
Software development and subscriptions
Rent & premises costs
Depreciation
Governance costs (see Note 6)
Apportioned to:
Costs of generating funds
Charitable activities
6
Analysis of governance costs
Independent examiners remuneration is broken down as follows:
Independent examination of the financial statements
Other governance costs include:
Accountancy
Legal & professional fees		 2025
2024
£
£
255,028
205,442
28,798
36,212
21,664
18,257
23,053
15,151
12,140
13,472
3,748
4,227
9,052
11,300
_
__
353,483
304,061
65,930
47,205
287,553
256,856
_
_
353,483
304,061
_

2025
2024
£
£
2,400
2,300
5,113
5,277
1,539
3,723

___
9,052
11,300
_

16

THE BRITISH DERMATOLOGICAL NURSING GROUP (Limited by Guarantee)

Notes forming part of the financial statements for the year ended 30 September 2025 (Continued)

7 Trustees and other employees

There were no trustees' remuneration or other benefits for the year ended 30th September 2025 nor for the year ended 30th September 2024.

Trustees had expenses reimbursed totalling £10,064 (2024 - £13,537) in respect of travel and subsistence.

No other related party transactions took place in the year that require disclosure.

8 Staff Costs 2025 2024
Wages and salaries 234,102 187,768
Social security costs 15,613 13,570
Pension costs 5,313 4,104
______ ______
255,028 205,442
______ ______
The average number of employees during the year was as follows:
2025 2024
Administration and education 8 6
______ ______
The number of employees and key management personnel whose employee benefits (excluding employer
pension costs) exceeded £70,000 was:
2025 2024
£70,001 - £80,000 1 1
______ ______
9 Fixed assets Computer software and
Office equipment
£
Cost
At 1 October 2024 17,233
______
At 30 September 2025 17,233
______
Depreciation
At 1 October 2024 10,507
Provided for the year 3,748
______
At 30 September 2025 14,255
______
Net book value
At 30 September 2025 2,978
____
At 30 September 2024 6,726
____

The number of employees and key management personnel whose employee benefits (excluding employer pension costs) exceeded £70,000 was:

17

THE BRITISH DERMATOLOGICAL NURSING GROUP

(Limited by Guarantee)

Notes forming part of the financial statements for the year ended 30 September 2025 (Continued)

10 Debtors
2025 2024
£ £
Trade debtors 202,420 392,210
Other debtors 500 -
Prepayments and accrued income 168,003 22,491
______ ______
370,923 414,701
______ ______
11 Creditors: amounts falling due within one year
2025 2024
£ £
Trade creditors 17,433 47,525
Other creditors 212,260 134,067
Accruals 95,619 26,746
Taxation 18,305 49,001
______ ______
343,617 257,339
______ ______
12 Unrestricted funds
Balance
Balance Incoming Outgoing 30 Sep
b/fwd Resources Resources 2025
£ £ £ £
Unrestricted funds
General fund 588,521 855,060 (727,840) 715,741
_ _ _ ______
Total Funds 588,521
_		 855,060
_		 (727,840)
_		 715,741
______

18